These statistics and biological mechanisms underscore just how extraordinary it is to encounter a case where anti-TIF1γ antibodies and ILD coexist, making our reported case an important contribution to the medical literature and our understanding of potential disease variations. The gene discussed is TRIM33; the disease is interstitial lung disease.